163 related articles for article (PubMed ID: 36948989)
41. Isolated Sulcal Effacement and Response to Intravenous Thrombolysis in Acute Ischemic Stroke.
Pektezel MY; Arsava EM; Gocmen R; Topcuoglu MA
J Stroke Cerebrovasc Dis; 2020 Oct; 29(10):105168. PubMed ID: 32912520
[TBL] [Abstract][Full Text] [Related]
42. Low- versus Standard-Dose Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke: An Updated Meta-Analysis.
Liu H; Zheng H; Cao Y; Pan Y; Wang D; Zhang R; You S; Zhang X; Li S; Tong X; Liu CF; Wang Y
J Stroke Cerebrovasc Dis; 2018 Apr; 27(4):988-997. PubMed ID: 29224744
[TBL] [Abstract][Full Text] [Related]
43. Multicenter Study of Adverse Events After Intravenous Tissue-Type Plasminogen Activator Treatment of Acute Ischemic Stroke.
Fernandez-Gotico H; Lightfoot T; Meighan M
J Neurosci Nurs; 2017 Feb; 49(1):31-36. PubMed ID: 28060219
[TBL] [Abstract][Full Text] [Related]
44. Preclusion of ischemic stroke patients from intravenous tissue plasminogen activator treatment for mild symptoms should not be based on low National Institutes of Health Stroke Scale Scores.
Wendt M; Tütüncü S; Fiebach JB; Scheitz JF; Audebert HJ; Nolte CH
J Stroke Cerebrovasc Dis; 2013 May; 22(4):550-3. PubMed ID: 23433783
[TBL] [Abstract][Full Text] [Related]
45. Current status of intravenous thrombolysis for acute ischemic stroke in Asia.
Sharma VK; Ng KW; Venketasubramanian N; Saqqur M; Teoh HL; Kaul S; Srivastava PM; Sergentanis T; Suwanwela N; Nguyen TH; Lawrence Wong KS; Chan BP
Int J Stroke; 2011 Dec; 6(6):523-30. PubMed ID: 22111797
[TBL] [Abstract][Full Text] [Related]
46. Recent Myocardial Infarction is Associated With Increased Risk in Older Adults With Acute Ischemic Stroke Receiving Thrombolytic Therapy.
Inohara T; Liang L; Kosinski AS; Smith EE; Schwamm LH; Hernandez AF; Bhatt DL; Fonarow GC; Peterson ED; Xian Y
J Am Heart Assoc; 2019 Aug; 8(15):e012450. PubMed ID: 31327296
[TBL] [Abstract][Full Text] [Related]
47. A new therapeutic strategy for acute ischemic stroke: sequential combined intravenous tPA-tenecteplase for proximal middle cerebral artery occlusion based on first results in 13 consecutive patients.
Smadja D; Chausson N; Joux J; Saint-Vil M; Signaté A; Edimonana M; Jeannin S; Bartoli B; Aveillan M; Cabre P; Olindo S
Stroke; 2011 Jun; 42(6):1644-7. PubMed ID: 21527758
[TBL] [Abstract][Full Text] [Related]
48. Medical Decision Making: Hyposphagma Prior to Intravenous Tissue Plasminogen Activator in Acute Ischemic Stroke.
Newey CR; Cueva W; Vellipuram A; Hornik A
J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):e181-2. PubMed ID: 27492945
[TBL] [Abstract][Full Text] [Related]
49. Intravenous thrombolysis for acute ischemic stroke.
Tomsick TA
J Vasc Interv Radiol; 2004 Jan; 15(1 Pt 2):S67-76. PubMed ID: 15106579
[TBL] [Abstract][Full Text] [Related]
50. IV tPA for acute ischemic stroke in the setting of intracranial tumor: A scoping review.
Moran CE; Rubin MN
J Stroke Cerebrovasc Dis; 2022 Oct; 31(10):106741. PubMed ID: 36030579
[TBL] [Abstract][Full Text] [Related]
51. Optimizing the management of acute ischaemic stroke: a review of the utilization of intravenous recombinant tissue plasminogen activator (tPA).
Eissa A; Krass I; Bajorek BV
J Clin Pharm Ther; 2012 Dec; 37(6):620-9. PubMed ID: 22708668
[TBL] [Abstract][Full Text] [Related]
52. Spinal epidural hematoma after intravenous thrombolysis for acute ischemic stroke.
Yeo LL; Lim JS; Sharma VK
J Neurol Sci; 2009 Sep; 284(1-2):190-1. PubMed ID: 19411083
[TBL] [Abstract][Full Text] [Related]
53. Angioedema from recombinant TPA administration: case report and pathophysiology review.
Foster-Goldman A; McCarthy D
Am J Ther; 2013; 20(6):691-3. PubMed ID: 24247033
[TBL] [Abstract][Full Text] [Related]
54. Predictors of in-hospital death and symptomatic intracranial hemorrhage in patients with acute ischemic stroke treated with thrombolytic therapy: Paul Coverdell Acute Stroke Registry 2008-2012.
Tong X; George MG; Yang Q; Gillespie C
Int J Stroke; 2014 Aug; 9(6):728-34. PubMed ID: 24024962
[TBL] [Abstract][Full Text] [Related]
55. Risk of Intracranial Hemorrhage Following Intravenous tPA (Tissue-Type Plasminogen Activator) for Acute Stroke Is Low in Children.
Amlie-Lefond C; Shaw DWW; Cooper A; Wainwright MS; Kirton A; Felling RJ; Abraham MG; Mackay MT; Dowling MM; Torres M; Rivkin MJ; Grabowski EF; Lee S; Kurz JE; McMillan HJ; Barry D; Lee-Eng J; Ichord RN
Stroke; 2020 Feb; 51(2):542-548. PubMed ID: 31842706
[TBL] [Abstract][Full Text] [Related]
56. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
[TBL] [Abstract][Full Text] [Related]
57. Remote Intracerebral Hemorrhage After Intravenous Thrombolysis: Results From a Multicenter Study.
Prats-Sánchez L; Camps-Renom P; Sotoca-Fernández J; Delgado-Mederos R; Martínez-Domeño A; Marín R; Almendrote M; Dorado L; Gomis M; Codas J; Llull L; Gómez González A; Roquer J; Purroy F; Gómez-Choco M; Cánovas D; Cocho D; Garces M; Abilleira S; Martí-Fàbregas J;
Stroke; 2016 Aug; 47(8):2003-9. PubMed ID: 27406103
[TBL] [Abstract][Full Text] [Related]
58. Tenecteplase use in the management of acute ischemic stroke: Literature review and clinical considerations.
Hailu K; Cannon C; Hayes S
Am J Health Syst Pharm; 2022 Jun; 79(12):944-949. PubMed ID: 35020806
[TBL] [Abstract][Full Text] [Related]
59. Impact of Tissue Plasminogen Activator Dosing on Patients Weighing More Than 100 kg on 3-Month Outcomes in Acute Ischemic Stroke.
Garavaglia J; Sherman J; Yetzer H; Regier M; Smith M
J Stroke Cerebrovasc Dis; 2017 May; 26(5):1041-1046. PubMed ID: 28129994
[TBL] [Abstract][Full Text] [Related]
60. Age-specific trends in intravenous thrombolysis and mechanical thrombectomy utilization in acute ischemic stroke in children under age 18.
Kaur N; Patel S; Ayanbadejo MO; Hoffman H; Akano E; Anikpezie N; Aneni E; Lamikanra O; Wee C; Albright K; Khandelwal P; Latorre JG; Chaturvedi S; Otite FO
Int J Stroke; 2023 Apr; 18(4):469-476. PubMed ID: 36250237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
